ACCESSWIRE
13 May 2022, 03:13 GMT+10
ALBUQUERQUE, NM / ACCESSWIRE / May 12, 2022 / Net Medical Xpress (OTC Pink:NMXS) announced today a correction from its previously reported unaudited financial results for the first fiscal quarter ended March 31, 2022.
The first quarter net income reported on an audited basis was $744,000, up from the previously reported unaudited net income for the quarter of $577,152. There was no change in the previously reported revenue of $1,907,000.
For more information, call 505-255-1999 X 320. Visit www.netmedical.com. Email ir@netmedical.com
About Net Medical - publicly traded (OTC Pink:NMXS) since 1999.
Net Medical has two operating units. Net Medical Labs is a moderate complex CLIA certified lab that specializes in virus testing and diagnostics. The company's mobile fleet of vans provide COVID and flu testing in New Mexico for schools, companies, homeless shelters and nursing homes. The company provides a unique Test-To-Treat program for home and office care that combines both diagnostic and pharmaceutical services that are particularly valuable in rural communities. The lab also serves as a reference lab for physician offices and other facilities that lack services for complex virus diagnostics. Net Medical Xpress provides telemedicine solutions for hospitals, nursing homes, specialty hospitals and other medical facilities. The company maintains a 24/7/365 call center, software developers and telemedicine platforms.
Forward-Looking Statements. This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are the company's current expectations about future events and can be identified by terms such as 'plans,' 'expect,' 'may,' 'anticipate,' 'intend,' 'should be,' 'will be,' 'is likely to,' 'believes,' and similar expressions referring to future periods. The company believes any expectations reflected in the forward-looking statements are reasonable but cannot guarantee future results, level of activity, performance or achievements. Actual results may differ materially from those expressed or implied in the forward-looking statements.
SOURCE: Net Medical Xpress Solutions, Inc.
Get a daily dose of Baltimore Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Baltimore Star.
More InformationDOLNI MORAVA, Czech Republic: The world's longest pedestrian suspension bridge has opened at a mountain resort in the Czech Republic. ...
SHAN STATE, Myanmar - According to an officer who participated in the assault, two local defense forces have destroyed a ...
TUNIS, Tunisia - The Tunisian navy said Saturday that it rescued 81 migrants, including 32 Bangladeshis, sailing from Libya to ...
ST. PETERSBURG, Florida: - A nearly $1 billion settlement has been agreed upon in a lawsuit brought by families of ...
The suspect is an 18-year-old white man heavily armed with tactical gear and a helmet, said Buffalo Police Commissioner Joseph ...
SAN JOSE, Costa Rica: President Rodrigo Chaves, who was sworn in as president on May 8, has declared a state ...
NEW YORK, New York - Weak economic news out of China undermined stocks on Wall Street on Monday. The major ...
ATLANTA, Georgia: Mercedes-Benz USA has requested drivers to stop driving some of their autos immediately due to braking problems.The announcement ...
KARACHI, Pakistan - The U.S. dollar climbed past Rs194 in the interbank market in Pakistan on Monday as analysts expressed ...
ROME, Italy: Italy has announced plans to sell state-owned ITA Airways, the successor to Alitalia, by the end of June, ...
SYDNEY, NSW, Australia - Stocks struggled for direction in Asia on Monday. Early gains evaporated later in the data, although ...
BEIJING, China: China's Green Valley Pharmaceutical company has prematurely ended an FDA approved study on its GV-971 to treat mild ...